Continue to Site >>>
Edit

Melissa Vonder Haar

Freelance Writer...

Articles by
Melissa Vonder Haar

Page 2
CBD/Hemp

What’s the ‘Next’ CBD?

Three cannabinoids that everyone will be talking about soon

CBD/Hemp

6 Insights Into the Mind of the CBD Consumer

Study suggests opportunity for mainstream retailers and manufacturers

CBD/Hemp

4 Months After the Farm Bill, Which Channel Is Winning CBD?

Drugstores take an early lead, but convenience channel is primed to battle back

CBD/Hemp

Gottlieb Calls for Congress to Act on CBD

Legal experts weigh in on the likelihood of action in Washington

CBD/Hemp

CBD Regulatory Update: 1st Quarter 2019

A number of state and local governments look to limit the sale of CBD-infused products

CBD/Hemp

CBD a 'Hard Challenge' for Regulators: FDA Commissioner

Agency will create a working group and hold public hearings in April

CBD/Hemp

Will the FDA Clamp Down on CBD?

What the agency has said about regulating hemp products

CSP Magazine

Every Ad Counts

The FDA is rolling out two retailer-centric ad campaigns. Will it have an impact?

CSP Magazine

Burning Bright

With a new direction from the FDA and the rise of smoking alternatives, category optimism is on the upswing

Tobacco

FDA Committee Rejects iQOS Modified-Risk Claim

Regulators will review recommendation, consider PMI’s reduced-risk arguments

Tobacco

Relationships Key to Battling Regulation

NACS official encourages retailers to reach out to lawmakers

CSP Magazine

Burning Questions in This New Era of Nicotine

Six topics discussed during CSP's 2017 Total Nicotine Conference

  • Page 2